RGC
Regencell Bioscience Holdings Limited$24.11
LiveJun 01, 2026
Market cap
$11.92B
52w range
9.39 – 83.60
P / E
—
EPS
—
Volume
31.15K
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Regencell Bioscience Holdings Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for RGC.
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.86% | +0.02% | -17.22% | -8.10% | +101.72% | +14.79% | +22.48% | +4127.02% | +8623.58% | +8623.58% | +8623.58% |
Aftermarket
LiveLast trade
$24.11
10 sh
Bid
$24.02
131 sh
Ask
$24.20
10 sh
Spread
$0.180
Sector & industry today
LiveSectors
- Technology+3.05%
- Energy+1.38%
- Industrials-0.37%
- Real Estate-0.38%
- Communication Services-0.39%
- Consumer Cyclical-0.53%
- Basic Materials-0.63%
- Consumer Defensive-0.64%
- Financial Services-0.75%
- Healthcare-0.81%
- Utilities-1.21%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-0.88%
- Computer Hardware+7.46%
- Coal+4.33%
- Semiconductors+4.06%
- Luxury Goods-3.55%
- Electronic Gaming & Multimedia-3.53%
- Paper, Lumber & Forest Products-2.65%
- Biotechnology-2.64%
- Integrated Freight & Logistics+2.54%
- Agricultural Farm Products+2.52%
- Software - Infrastructure+2.47%
- Internet Content & Information-2.15%
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harmfeeds.newsfilecorp.com·May 13, 2026
- Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harmglobenewswire.com·May 13, 2026
- RGC CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Deadline on June 23, 2026newsfilecorp.com·May 13, 2026
- RGC DEADLINE: Levi & Korsinsky Reminds Regencell Bioscience Holdings Limited Investors of Upcoming Securities Class Action Deadlineprnewswire.com·May 13, 2026
- ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGCnewsfilecorp.com·May 12, 2026
- ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGCnewsfilecorp.com·May 12, 2026
- ROSEN, LEADING INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGCglobenewswire.com·May 12, 2026
- ROSEN, LEADING INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGCglobenewswire.com·May 12, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|